Výsledky vyhledávání - "Holger Gellermann"

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)

Autor: Jaime Andrade-Villanueva, V. Soriano, B Clotet, Peter Reiss, V. Cairns, Juergen K. Rockstroh, Pere Domingo, Holger Gellermann, L. de Rossi, Daniel Podzamczer, Steve Taylor

Publikováno v: HIV Medicine. 12:374-382

Objectives Dyslipidaemic effects of antiretrovirals (ARVs) may contribute to increased cardiovascular risk (CR) in HIV-1-infected patients. The ARTEN (atazanavir/ritonavir on a background of tenofovir and emtricitabine vs. nevirapine on the same back

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7be515953c3a8cba42f7bb37a9276029
https://doi.org/10.1111/j.1468-1293.2011.00917.x

Zobrazit plný text záznamu

Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy

Autor: Werner Kadus, Vicente Soriano, María del Mar González, Manuel Distel, Holger Gellermann, Eduardo Seclén, Eva Poveda, Luz Martín-Carbonero

Publikováno v: Journal of Infectious Diseases; Vol 204

Viral tropism influences the natural history of human immunodeficiency type 1 (HIV-1) disease: X4 viruses are associated with faster decreases in CD4 cell count. There is scarce information about the influence of viral tropism on treatment outcomes.B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff7a8a109ab987684b23e13e2f2df9a
https://pubmed.ncbi.nlm.nih.gov/21628668

Zobrazit plný text záznamu

Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN trial

Autor: Daniel Podzamczer, Giovanni Di Perri, Jaime Andrade-Villanueva, Milos Opravil, Thomas Lutz, Vicente Soriano, Pere Domingo, Keikawus Arastéh, Francisco Antunes, Holger Gellermann, Steve Taylor, Lothar de Rossi, Horacio Migrone

Publikováno v: ANTIVIRAL THERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background Selection of first-line antiretroviral therapy requires consideration of efficacy as well as effects on lipids given the increased concern about cardiovascular risk in HIV-1 patients. Methods ARTEN is a randomized, open-label, non-inferior

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4467206e957452ac3452da644cdec5f
https://www.zora.uzh.ch/id/eprint/48415/

Zobrazit plný text záznamu

Detection of minor populations of drug-resistant HIV-1 in acute seroconverters

Autor: Karin J. Metzner, Bernhard Zöllner, Knud Schewe, Holger Gellermann, Heiko Jessen, Hans-Jürgen Stellbrink, Stefan Fenske, Hauke Walter, Christoph Boesecke, Pia Rauch

Publikováno v: AIDS (London, England). 19(16)

Objective: The transmission of drug-resistant HIV-1 is a major health concern. To date, most clinical studies have relied on sequencing techniques for genotypic analyses which do not allow quantification of minority viral populations below 25%. As mi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254e8b292ba5034bd252633b2c65c9c0
https://pubmed.ncbi.nlm.nih.gov/16227789

Zobrazit plný text záznamu

Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex

Autor: Holger Gellermann, Mark A. Jacobson, Henry F. Chambers

Publikováno v: The American journal of medicine. 85(2)

Purpose An increased incidence of Staphylococcus aureus bacteremia has recently been described in patients with the acquired immunodeficiency syndrome (AIDS). However, other risk factors for community-acquired S. aureus bacteremia (including intraven

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2782647ccc01852d28763ffb06e437b
https://pubmed.ncbi.nlm.nih.gov/3400693

Zobrazit plný text záznamu

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients

Autor: V. Soriano, V Cairns, Holger Gellermann, Manuel Distel, Eva Poveda, Luz Martín-Carbonero, María del Mar González, Eduardo Seclén, Werner Kadus

Publikováno v: Journal of the International AIDS Society

Purpose: To evaluate the influence of HIV-1 tropism on virologic and immunologic responses in antiretroviral-naive HIV-1-infected patients enrolled in the ArTEN trial (atazanavir/r vs. nevirapine along with tenofovir/emtricitabine). Methods: Baseline

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4af8e29805e140ec58bc4f837b49c787

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání